SMARCA4 vulnerability in H3K27M midline glioma: A silver bullet for a lethal disease.

Animals Humans Glioma / genetics Mammals DNA Helicases / genetics Nuclear Proteins Transcription Factors

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
19 Jan 2023
Historique:
received: 23 12 2022
revised: 23 12 2022
accepted: 23 12 2022
entrez: 20 1 2023
pubmed: 21 1 2023
medline: 25 1 2023
Statut: ppublish

Résumé

To investigate epigenetic dependencies and identify therapeutic vulnerabilities, Mo et al.

Identifiants

DOI: 10.1016/j.molcel.2022.12.028 PMID: 36669477
pubmed: 36669477
pii: S1097-2765(22)01211-4
doi: 10.1016/j.molcel.2022.12.028
pii:
doi:

Substances chimiques

SMARCA4 protein, human EC 3.6.1.-
DNA Helicases EC 3.6.4.-
Nuclear Proteins 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-164

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Carol C L Chen (CCL)

Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.

Augusto Faria Andrade (AF)

Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.

Nada Jabado (N)

Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada; Department of Pediatrics, McGill University, and The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada. Electronic address: nada.jabado@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › SMARCA4 vulnerability in H3K27M midline...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › SMARCA4 vulnerability in H3K27M midline...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroépitheliales › Gliome › SMARCA4 vulnerability in H3K27M midline...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › SMARCA4 vulnerability in H3K27M midline...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Isomerases › Helicase › SMARCA4 vulnerability in H3K27M midline...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines nucléaires › SMARCA4 vulnerability in H3K27M midline...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › SMARCA4 vulnerability in H3K27M midline...